Im very happy to buy at these prices - with all the trials we have under way funded by the various researcher partners and with no further contribution to GBM yet 150 patients in the Pax arm and the 300 odd in the control arm adds massively to data to date.
Q - what do you think about Patrick Wen on our science board and his involvement in the GBM Agile study?
How many KZA have you snapped up recently now you are actively back on KZA…
thanks for helping me into some cheap shares - you’re terrible!
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia presents to Bell Potter Healthcare Conference
Ann: Kazia presents to Bell Potter Healthcare Conference, page-17
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity